Home / Private raises / Placement agents / J.P. Morgan Institutional Investments Inc.
J.P. Morgan Institutional Investments Inc.
Placement agent · New York, NY · named on 8 Form D filings
- Filings
- 8
- Issuers
- 8
- Fund raises
- 8
- Sold (new filings)
- $0
Raises it was paid to sell
| Filed | Issuer | Industry | Place | Sold | Offered | Investors | Type | |
|---|---|---|---|---|---|---|---|---|
| Oct 26 | Institutional Credit Fund, L.P.update | Hedge Fund | New York, NY | $494M | Open-ended | 27 | 506(b), 3(c), 3(c)(7) | SEC ↗ |
| Oct 9 | U.S. Large Cap 130/30 Fund, LLCupdate | Other Investment Fund | New York, NY | $2.2B | Open-ended | 49 | 506(b), 3(c), 3(c)(7) | SEC ↗ |
| Sep 29 | 270 Healthcare Growth Fund I (LUX) SCSp-RAIFupdate | Private Equity Fund | Luxembourg, N4 | $114M | Open-ended | 18 | 506(b), 3(c), 3(c)(1), 3(c)(7) | SEC ↗ |
| Sep 29 | 270 Healthcare Growth Fund I LPupdate | Private Equity Fund | New York, NY | $114M | Open-ended | 27 | 506(b), 3(c), 3(c)(1), 3(c)(7) | SEC ↗ |
| Sep 16 | 270 Hybrid Growth Cayman Fund, LP | Other Investment Fund | New York, NY | $0 | Open-ended | 0 | 506(b), 3(c), 3(c)(1), 3(c)(7) | SEC ↗ |
| Sep 16 | 270 Hybrid Growth Onshore Fund, LP | Other Investment Fund | New York, NY | $0 | Open-ended | 0 | 506(b), 3(c), 3(c)(1), 3(c)(7) | SEC ↗ |
| Sep 16 | 270 Life Sciences Private Capital Fund II (Cayman) LP | Venture Capital Fund | New York, NY | $0 | Open-ended | 0 | 506(b), 3(c), 3(c)(1), 3(c)(7) | SEC ↗ |
| Sep 16 | 270 Life Sciences Private Capital Fund II (US) LP | Venture Capital Fund | New York, NY | $0 | Open-ended | 0 | 506(b), 3(c), 3(c)(1), 3(c)(7) | SEC ↗ |
From the "sales compensation" section of SEC Form D: the broker-dealers an issuer reports paying to sell its offering. Check a firm's registration and disciplinary history on FINRA BrokerCheck. Not investment advice.
How are we doing?
